drugset / Trial / NCT00370734

Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease

NCT00370734

Phase 2/3 Unknown 50 enrolled Shahid Beheshti University of Medical Sciences
Non-randomizedSingle-groupOpen-labelTreatment

Summary

In active phase of thyroid eye disease some patients have obvious upper lid retraction , and sometimes exposure keratopathy .To date there is not any standard treatment for this situation . We are going to compare the natural course of the upper lid retraction with injection of botulinum toxin A injection to upper lid percutaneously.

Timeline

Start
2005-05
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic Other

Indications